Some previous reports have suggested that patients with breast cancer who have PIK3CA mutations, have a better prognosis than others [29], whereas other authors have suggested that PIK3CA mutations are associated with a worse prognosis in colorectal cancer, endometrial cancer and lung cancer patients [30–32]. The gene discussed is PIK3CA; the disease is lung cancer.